Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Regulus Therapeutics
AddedFeb 19, 2024
UpdatedJun 18, 2026
Regulus Therapeutics

Regulus Therapeutics

Public

San Diego-based Regulus Therapeutics Inc. pioneers first-in-class drugs targeting microRNAs for diverse diseases.

HQ
San Diego, CA, US
Founded
2007
Overview
Compare
Fundraising
Employees
Website

Regulus Therapeutics Inc., founded in September 2007 by Alnylam Pharmaceuticals and Isis Pharmaceuticals, is a clinical-stage biopharmaceutical company based in San Diego, California. The company's core mission is to develop first-in-class drugs that target microRNAs to treat a broad range of diseases, with a particular focus on orphan kidney diseases such as Autosomal Dominant Polycystic Kidney Disease (ADPKD). Regulus leverages its expertise in microRNA-based therapeutics to address high unmet medical needs, aiming to improve the lives of patients and their families.

Notable affiliated individuals include founders from Alnylam Pharmaceuticals and Isis Pharmaceuticals. Regulus has garnered attention for its innovative approach and has achieved significant milestones, including positive topline data from clinical trials. The company's pioneering work in microRNA therapeutics has positioned it as a leader in the biopharmaceutical industry, making a substantial impact on the treatment landscape for kidney diseases.

Regulus Therapeutics - Similar Companies

Regel Therapeutics logo

Regel Therapeutics

Regor Therapeutics logo

Regor Therapeutics

Regulonix Holding logo

Regulonix Holding

Ionis Pharmaceuticals logo

Ionis Pharmaceuticals

ionispharma.com

Alnylam Pharmaceuticals aln logo

Alnylam Pharmaceuticals aln

alnylam.com

Rigel Pharmaceuticals logo

Rigel Pharmaceuticals

rigel.com

RegeneRx Biopharmaceuticals logo

RegeneRx Biopharmaceuticals

Fulcrum Therapeutics logo

Fulcrum Therapeutics

fulcrumtx.com

Akebia Therapeutics logo

Akebia Therapeutics

akebia.com

Orbital Therapeutics logo

Orbital Therapeutics

Renibus Therapeutics logo

Renibus Therapeutics

Arcturus Therapeutics Holdings logo

Arcturus Therapeutics Holdings

arcturusrx.com

Nextrna Therapeutics logo

Nextrna Therapeutics

Nephrogen logo

Nephrogen

PTC Therapeutics logo

PTC Therapeutics

ptcbio.com

Regulus Therapeutics - Quick Facts

Who are Regulus Therapeutics' competitors?

Companies similar to Regulus Therapeutics include Regel Therapeutics, Regor Therapeutics, Regulonix Holding and Ionis Pharmaceuticals.

When was Regulus Therapeutics founded?

Regulus Therapeutics was founded in 2007.

Where is Regulus Therapeutics' headquarters located?

Regulus Therapeutics' headquarters is located in San Diego, CA, US.

When was Regulus Therapeutics' last funding round?

Regulus Therapeutics' most recent funding round was for $15M (USD) in April 2023.

How much has Regulus Therapeutics raised to-date?

As of Apr 13, 2023, Regulus Therapeutics has raised a total of $380.9M (USD).

How many employees does Regulus Therapeutics have?

Regulus Therapeutics has 30 employees as of Feb 6, 2024.

Regulus Therapeutics - Classification

Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Therapeutics
Tags
  • Healthtech
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 14 more industry codes
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 620000Health Care and Social Assistance
  • 541000Professional, Scientific, and Technical Services
  • 623000Nursing and Residential Care Facilities
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 4000Railroad Transportation
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research